Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum - ScienceDirect
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease - Rosebraugh - 2021 - Annals of Neurology - Wiley Online Library
Closing the loop for patients with Parkinson disease: where are we? | Nature Reviews Neurology
203952Orig1s000
Subcutaneous Levodopa/Carbidopa Delivery Provides Potential Breakthrough in Parkinson Disease
Subcutaneous Levodopa/Carbidopa Delivery Provides Potential Breakthrough in Parkinson Disease
Carbidopa/Levodopa Formulations & Parkinson's Disease | APDA
Parkinson: Stabile Levodopa-Spiegel nach subkutaner Infusion | Gelbe Liste
Pharmaceutics | Free Full-Text | Prodrug Therapies for Infectious and Neurodegenerative Diseases
Expert Exchange: Perspectives on Established and Emerging Therapies for OFF Symptoms in Parkinson Disease
Levodopa belt pump 29 (permission granted by NeuroDerm). | Download Scientific Diagram
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial - The Lancet Neurology
New Analyses Find Duopa Improves Parkinson's Symptom Control | 1 Year of Treatment Found to Ease Motor Fluctuations in Patients | Parkinson's News Today
Untitled
Untitled
For Advanced Parkinson's, ABBV-951 Aims for 24-hour Levodopa Infusion
Subcutaneous ABBV-951 Infusion Superior in Parkinson Disease to Oral Formulation
24-hour Subcutaneous Foslevodopa/Foscarbidopa Demonstrates Several Benefits for Parkinson Disease
AbbVie files continuous Parkinson's therapy ABBV-951 in US | pharmaphorum
Carbidopa/Levodopa Formulations & Parkinson's Disease | APDA
Objectives METHODS
AbbVie's Parkinson's pump hits goal in phase 3, setting stage for approval filings | Fierce Pharma
Scalable Asymmetric Syntheses of Foslevodopa and Foscarbidopa Drug Substances for the Treatment of Parkinson's Disease | The Journal of Organic Chemistry
